Centrum 7/6  banner

Lilly’s chairman and chief executive officer

Lilly to introduce lower-priced insulin

Lilly to introduce lower-priced insulin

INDIANAPOLIS — Reinforcing their commitment to lower out-of-pocket costs for people who need insulin, Eli Lilly and Co. announced it will introduce a lower-priced version of Humalog (insulin lispro injection 100 units/mL) in the United States — providing people with diabetes an insulin option that will have a list price 50 percent lower than the current

PP_1170x120_10-25-21